Ipsen Pharma (SAS)

Ipsen Pharma (SAS) is a mid-sized global biopharmaceutical company with nearly 100 years of development experience. We are dedicated to pioneering transformative medicines, focusing on Oncology, Rare Disease, and Neuroscience. Our mission is to tackle areas of high unmet medical need through continuous research and innovation, bringing valuable solutions to patients around the world.

Operating globally with teams in over 40 countries and serving patients in 88, Ipsen Pharma (SAS) maintains global hubs in the U.S., France, and the U.K. We champion a human-centric leadership and foster a culture of collaboration, excellence, and impact, where every individual is empowered to thrive. Join us in our journey towards sustainable growth, creating real impact on patients and society.